UnitedHealth (NYSE: UNH) Just Broke Out and Could Rise 11%-27% Higher

We flagged UnitedHealth Group (NYSE: UNH) in one of our earlier breakout watchlists — and the stock has now broken out of a six-month symmetrical triangle and looks headed even higher.

As we’ll get to just ahead, the combination of a decisive earnings beat that has management raising its outlook yet again, clear signs that a hard-fought business turnaround is gaining traction, and a fresh technical breakout makes UNH one of the more interesting setups on the board. Here’s what’s going on…

The Themes Behind the Move

UnitedHealth Group is the largest health insurer in the U.S. and one of the biggest health care companies in the world. It operates through two giant businesses: UnitedHealthcare, which sells health plans to employers, individuals, Medicare retirees, and state Medicaid programs, and Optum, which runs doctor networks and clinics (Optum Health), health-care software and data services (Optum Insight), and one of the nation’s largest pharmacy benefit managers (Optum Rx).

In plain English, when an employer buys health coverage for its workers, a retiree picks a Medicare plan, or a doctor’s office needs a prescription filled or a claim processed, there’s a good chance UnitedHealth is involved somewhere along the way. Its business hinges on one thing above all: keeping the cost of patient care in check relative to the premiums it collects — a balance that came under heavy pressure in 2025 and that the company has spent the past year repairing.

UNH’s latest move reflects a powerful confluence of developments — financial, operational, and strategic — that have come together in rapid succession to fundamentally reframe the company’s recovery story.

If needed, swipe or scroll sideways to view the full table.

Put it all together, and UNH is looking less like a fallen giant still searching for a bottom and more like a turnaround with real numbers behind it — rising margins, a recovering Optum Health, another guidance raise, and a management team openly pointing to double-digit earnings growth in 2027.

The story is getting stronger, but the chart is what could determine whether this move has more room to run in the near term. Here are the bullish technical signals traders should be watching now.

Bullish Technical Signals

#1 Symmetrical Triangle Breakout (Daily): UNH has broken out of a symmetrical triangle that took roughly six months to form. The rising lower trendline starts at the April low near $258, and the falling upper trendline starts at the mid-July spike above $460. Over the summer and early fall, price made lower highs and higher lows, squeezing into a tighter range as buyers and sellers reached a standoff. The breakout above the upper trendline resolves that standoff upward, which matches the prior trend: the April-to-July advance was the dominant move before the pattern formed. Thursday’s session confirmed the move. The stock gapped up from $395.62 and closed at $406.67 (+2.79%), lifting price clearly away from the trendline rather than just poking above it. Volume has picked up into the breakout, but it is steady rather than explosive. The intraday high of $414.12 stalled right at the $414 horizontal level, so a close above $414 is the confirmation that opens the path toward the July highs.

UNH – Daily Chart

#2 Price Above 50-Day and 200-Day SMAs (Daily): UNH closed above both key moving averages: the 50-day SMA at $387.35 and the 200-day SMA at $358.75. The 50-day has been above the 200-day since the golden cross in late spring, so the long-term structure has stayed bullish through the entire triangle consolidation. That matters because the pullback since July was a correction inside an uptrend, not a trend reversal. The breakout also took back the 50-day, which had capped price for most of September and early October. That old ceiling now becomes the first line of dynamic support. Support is now tiered: $395 (the gap-fill zone and the pullback entry), then the 50-day near $387, then the 200-day near $359. One caveat is that the 50-day has been sloping gently lower since its August peak. Price staying above it is what should flatten that slope and turn it back up.

#3 Bullish ADX and DI (Daily): The ADX setup shows both direction and strength turning in the bulls’ favor. +DI at 32.97 sits nearly 22 points above –DI at 11.39, a wide gap that leaves no doubt buyers are setting direction while selling pressure has faded. The more telling detail is the ADX line itself. It has turned up from a trough below both DI lines and now reads 25.60, sitting between them and just above the 25 threshold that separates a trending market from a directionless one. Because ADX measures trend strength regardless of direction, a climb from a compressed base like this signals a new trend gaining force, not an old one running out of steam. An ADX that has only just crossed 25 means this move is in its early stages, with plenty of room before the trend looks stretched. Together with the triangle breakout in #1, the ADX upturn marks the point where months of sideways compression turned into directional movement.

#4 Bullish Aroon (Daily): The Aroon indicator is in its strongest bullish setup: Aroon Up (orange) is at 100% and Aroon Down (blue) has fallen to 28.57%. An Aroon Up reading of 100 means UNH has just set a new high within the 14-session lookback window, as you’d expect after a breakout. Aroon Up has stayed near its ceiling for more than a week, which means the stock has been setting new highs repeatedly, not just once. Meanwhile, the steady slide in Aroon Down shows the last meaningful low is slipping further into the past. The wide gap between the two lines points to a one-sided market, with buyers active and sellers largely absent, which is what you want to see behind a fresh pattern breakout.

#5 Bounce From Support Area, Price Above 50-Week SMA (Weekly): The weekly chart shows exactly where buyers stepped in. This week’s low of $372.80 tested the $372.48 support area (pink dotted line) almost to the cent and reversed sharply into a +7.22% weekly gain, the strongest weekly candle in months, on rising volume. The level has history behind it. It capped the late-2025 rebound attempts, then flipped to support during the 2026 recovery. Levels that switch roles like this are the ones the market tends to respect. Below that support, the rising 50-week SMA at $354.77 adds a second layer of defense. The 50-week has curled upward since the spring and is now carrying the recovery trend. The key overhead level is the 200-week SMA at $448.74. Price still trades below it, and that average is still sloping lower. The July rally stalled right beneath it, so a weekly close above the 200-week, which sits next to Price Target 1 at $460, is the step that would turn this recovery into a full long-term trend reversal.

UNH – Weekly Chart

#6 Stochastic Crossover From Oversold (Weekly): On the weekly chart, %K (blue) has climbed out of oversold territory and crossed above %D (orange), reaching 44.51 against 23.59. The location gives this crossover more weight than a mid-range cross: it happened below the 20 level, after the September–October pullback had fully worn out selling pressure. The gap of more than 20 points between the lines shows %K turning sharply, not just edging over its signal line. The weekly timeframe matters too. Weekly stochastic signals filter out much of the noise that makes daily crossovers unreliable. The last time this indicator went through this sequence, in spring 2026, it came before the advance from the $260s toward $460. With %K still far below 80, the oscillator has a lot of room before overbought conditions become a headwind.

#7 Bullish RSI (Weekly): The weekly RSI has turned back up to 59.45 and crossed above its signal line at 55.81. Both parts of that move are bullish. First, RSI dipped into the high 40s during the pullback and has now recovered above the 50 midline, handing momentum control back to buyers after a brief stretch in neutral territory. Second, it is rising steeply rather than leveling off, which shows momentum is building. The crossover above its signal line adds confirmation that the turn is real and not a one-week blip. At just under 60, RSI sits well below the 70 overbought level it reached at the July peak, leaving room for further gains. Combined with the stochastic crossover in #6 and the support bounce in #5, all three weekly signals now agree with the daily breakout. That kind of agreement across timeframes carries more weight than either timeframe alone.

Risks to Consider

Even strong setups can fail, especially in a heavily regulated turnaround story like UnitedHealth. A few things could knock the stock off course:

• A breakdown back below the symmetrical triangle support level on heavy volume would invalidate the breakout thesis
• Negative company-specific news, broader market weakness, or regulatory changes in the managed-care sector could trigger a sell-off
• Earnings-quality risk — Q3’s margin improvement was helped by $610 million of favorable prior-period reserve development (money set aside for past claims that ultimately wasn’t needed), so not all of it should be treated as recurring. A renewed jump in hospital usage or specialty-drug costs could reverse the gains
• Shrinking membership and revenue — UnitedHealthcare served 48.3 million people, down from ~50.1 million a year ago, including ~935,000 fewer Medicare Advantage members since year-end 2025, while Q3 revenue slipped ~0.4% year over year
• Weaker quality scores — roughly 69% of UNH’s Medicare Advantage members are now in plans rated 4 stars or higher, down from ~78%, which could reduce future government bonus payments — though the main financial impact doesn’t hit until 2028 (2027 Star Ratings)
• Unresolved regulatory and legal overhang — Department of Justice scrutiny tied to Medicare billing and Optum Rx practices remains open, alongside broader political pressure on Medicare Advantage payments, including a Senate report criticizing the company’s tactics
• Competition — rival insurers are fighting harder for profitable members during open enrollment, and Humana emerged as a major relative winner in the latest Star Ratings
• Execution and valuation risk — the market increasingly assumes continued earnings normalization in 2027, so a medical-cost miss, weaker enrollment economics, or a failure to deliver double-digit EPS growth could trigger a sharp de-rating

The Bottom Line

UNH is breaking out of a six-month symmetrical triangle on the daily chart while bouncing off a key resistance-turned-support level on the weekly — a dual-timeframe technical setup that historically signals the start of a sustained move higher.

The fundamental story underneath the chart is just as strong: a decisive third-quarter beat-and-raise, a turnaround spreading across its biggest businesses, and a management team pointing to double-digit earnings growth in 2027.

Combine that with multiple catalysts staggered through the coming months — Medicare open enrollment through December 7, the start of the 2027 plan year on January 1, and Q4 results in late January — plus a clean runway with no earnings report until then, and UNH looks like one of the more compelling risk-reward setups on the board right now.

If this is a trade you want to get in on, here’s how we’d play it. Below you’ll find our two entry options — one on a breakout, one on a pullback — both price targets that imply 11%–27% potential upside depending on your entry, and the stop-losses we’re using to manage the downside.

Recommended Trade Setup

Option 1: Buy on a Breakout

If needed, swipe or scroll sideways to view the full table.

For a risk of approximately $28.00 per share, the target rewards are about $46.00 and $86.00 per share. That makes this roughly a 1:2 and 1:3 risk-reward trade. In other words, the setup offers nearly 2x to 3x more potential upside than downside.

Note on Trade Invalidation: This recommendation stays active as long as the technical structure holds. If UNH drops to or below the $386.00 stop-loss before the $414.00 entry triggers, the trade is automatically void — the support underpinning the thesis would have broken, and the risk-reward setup would no longer justify entry.

Option 2: Buy on a Pullback

If needed, swipe or scroll sideways to view the full table.

For a risk of approximately $33.00 per share, the target rewards are about $65.00 and $105.00 per share. That makes this roughly a 1:2 and 1:3 risk-reward trade. In other words, the setup offers nearly 2x to 3x more potential upside than downside.

Happy Trading!
Tara and Greg